Skip to main content

Advertisement

Table 4 Frequencies of chemotherapy-related acute toxicities among the patients

From: Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy

Toxicity Grade 0, n (%) Grade 1, n (%) Grade 2, n (%) Grade 3, n (%) Grade 4, n (%)
Induction chemotherapy (n = 41)
 Leukopenia 12 (29.3) 7 (17.1) 15 (36.6) 6 (14.6) 1 (2.4)
 Anemia 38 (92.7) 2 (4.9) 1 (2.4) 0 0
 Thrombocytopenia 37 (90.2) 2 (4.9) 2 (4.9) 0 0
 Liver dysfunction 41 (100) 0 0 0 0
 Renal dysfunction 41 (100) 0 0 0 0
Adjuvant chemotherapy (n = 33)
 Leukopenia 9 (27.3) 5 (15.2) 5 (15.2) 9 (27.3) 5 (15.2)
 Anemia 29 (87.9) 4 (12.1) 0 0 0
 Thrombocytopenia 31 (93.9) 2 (6.1) 0 0 0
 Liver dysfunction 33 (100) 0 0 0 0
 Renal dysfunction 32 (97.0) 1 (3.0) 0 0 0
  1. No radiotherapy-related late neurological toxicities, such as cranial nerve palsy, temporal lobe necrosis, brain stem injury, or spinal cord injury, were observed